カテゴリ： MarketLine, アメリカ, 企業調査

Ultragenyx Pharmaceutical Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4165
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：49
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Ultragenyx Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Ultragenyx Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ultragenyx Pharmaceutical Inc. (Ultragenyx or ‘the company’) is a clinical-stage bio-pharmaceutical company. The company classifies its business in a single business: the identification, acquisition, development and commercialization of novel products for the treatment of rare and ultra-rare diseases. It develops KRN23 (UX023) for the treatment of X-linked hypophosphatemia (XLH, a rare genetic disease that impairs bone growth); and tumor-induced osteomalacia It mainly operates in the US. The company also has a partnership with Takeda Pharmaceutical Company Limited to develop and commercialize therapies to treat rare genetic diseases. Ultragenyx is headquartered in Novato, California, the US.

Scope

- Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on Ultragenyx Pharmaceutical Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ultragenyx Pharmaceutical Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Ultragenyx Pharmaceutical Inc.: Company Overview
Ultragenyx Pharmaceutical Inc.: Overview and Key Facts
Ultragenyx Pharmaceutical Inc.: Overview
Ultragenyx Pharmaceutical Inc.: Key Facts
Ultragenyx Pharmaceutical Inc.: Key Employees
Ultragenyx Pharmaceutical Inc.: Key Employee Biographies
Ultragenyx Pharmaceutical Inc.: Major Products and Services
Ultragenyx Pharmaceutical Inc.: Company History
Ultragenyx Pharmaceutical Inc.: Management Statement
Ultragenyx Pharmaceutical Inc.: Key Competitors
Ultragenyx Pharmaceutical Inc.: Company Analysis
Ultragenyx Pharmaceutical Inc.: Business Description
Ultragenyx Pharmaceutical Inc.: SWOT Analysis
Ultragenyx Pharmaceutical Inc.: SWOT Overview
Ultragenyx Pharmaceutical Inc.: Strengths
Ultragenyx Pharmaceutical Inc.: Weaknesses
Ultragenyx Pharmaceutical Inc.: Opportunities
Ultragenyx Pharmaceutical Inc.: Threats
Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity
Ultragenyx Pharmaceutical Inc.: Financial Deals Overview
Ultragenyx Pharmaceutical Inc.: Targets and Partners
Ultragenyx Pharmaceutical Inc.: Top Deals 2016 – 2020YTD*
Ultragenyx Pharmaceutical Inc.: Advisors
Ultragenyx Pharmaceutical Inc.: Top Legal Advisors
Ultragenyx Pharmaceutical Inc.: Top Financial Advisors
Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions
Ultragenyx Pharmaceutical Inc.: Capital Raising
Ultragenyx Pharmaceutical Inc.: Partnership
Ultragenyx Pharmaceutical Inc.: Divestments
Ultragenyx Pharmaceutical Inc.: Recent Developments
Ultragenyx Pharmaceutical Inc.: News and Events Summary
Ultragenyx Pharmaceutical Inc.: Corporate Governance
Ultragenyx Pharmaceutical Inc.: Financial Performance
Ultragenyx Pharmaceutical Inc.: Market Developments
Ultragenyx Pharmaceutical Inc.: Research & Development
Ultragenyx Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Ultragenyx Pharmaceutical Inc.: Key Facts
Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees
Table 3: Ultragenyx Pharmaceutical Inc.: Company History
Table 4: Ultragenyx Pharmaceutical Inc.: Key Competitors
Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Ultragenyx Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Ultragenyx Pharmaceutical Inc.: Targets and Partners
Table 9: Ultragenyx Pharmaceutical Inc.: Top Deals 2016 - 2020YTD*
Table 10: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: Ultragenyx Pharmaceutical Inc.: News and Events Summary
Table 20: Ultragenyx Pharmaceutical Inc.: Corporate Governance
Table 21: Ultragenyx Pharmaceutical Inc.: Financial Performance
Table 22: Ultragenyx Pharmaceutical Inc.: Market Developments
Table 23: Ultragenyx Pharmaceutical Inc.: Research & Development
Table 24: Ultragenyx Pharmaceutical Inc.: Strategy and Operations

★海外企業調査レポート[Ultragenyx Pharmaceutical Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • MedMira Inc (MIR)：企業の財務・戦略的SWOT分析
    Summary MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the …
  • Inditex SA (ITX)：企業の財務・戦略的SWOT分析
    Inditex SA (ITX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Entertainment One Ltd.：企業のM&A・事業提携・投資動向
    Entertainment One Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Entertainment One Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Genedata AG-医療機器分野：企業M&A・提携分析
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • PaR Systems LLC：企業の戦略的SWOT分析
    PaR Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • F. Hoffmann-La Roche Ltd：戦略・SWOT・企業財務分析
    F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report Summary F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Manitoba Hydro-Electric Board：企業の発電所・SWOT分析2018
    Manitoba Hydro-Electric Board - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • VIDA Diagnostics Inc：医療機器：M&Aディール及び事業提携情報
    Summary VIDA Diagnostics Inc (VIDA) is a medical technology company that provides clinical imaging software and analysis services for early detection, evaluation, and treatment of pulmonary diseases. The company offers VIDA exchange and VIDA vision. Its products are used in airway mapping, lung volu …
  • ITT Inc (ITT)：企業の財務・戦略的SWOT分析
    ITT Inc (ITT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Navistar International Corporation (NAV)：企業の財務・戦略的SWOT分析
    Navistar International Corporation (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Boart Longyear Ltd：企業の戦略・SWOT・財務分析
    Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report Summary Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CK Infrastructure Holdings Ltd (1038)：電力：M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …
  • Nokia Corp (NOKIA)：企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cinnabon LLC：企業の戦略・SWOT・財務情報
    Cinnabon LLC - Strategy, SWOT and Corporate Finance Report Summary Cinnabon LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Epax Norway AS：戦略・SWOT・企業財務分析
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Linde AG, Engineering：企業の戦略的SWOT分析
    Linde AG, Engineering - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Nanjing Pharmaceutical Co Ltd (600713)：企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • BCD Travel Services B.V.：戦略・SWOT・企業財務分析
    BCD Travel Services B.V. - Strategy, SWOT and Corporate Finance Report Summary BCD Travel Services B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Resources Wandong Medical Equipment Co Ltd (600055)：医療機器：M&Aディール及び事業提携情報
    Summary China Resources Wandong Medical Equipment Co Ltd (Wandong Medical Equipment), formerly Beijing Wandong Medical Equipment Co Ltd, a subsidiary of Beijing Pharmaceutical Group Co Ltd, is a medical device company that develops and markets medical devices and equipment. The company’s products in …
  • Sol-Gel Technologies Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Sol-Gel Technologies Ltd (Sol-Gel) is a developer and manufacturer of topical dermatological drug products. The company’s products include Cool Pearls anti acne kit which is a benzoyl peroxide-based acne regime at commercial stage; and SGT-VD-54 is a non-antibiotic topical drug for the treat …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆